Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: A nationwide population-based study

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 118, Issue 11, 2011, Pages 1365-1373

  Chen, C H ^a,b,c   Xirasagar, S ^d   Lin, C C ^e   Wang, L H ^e   Kou, Y R ^a   Lin, H C ^e  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c Nursing   (Taiwan)

^d UNIVERSITY OF SOUTH CAROLINA   (United States)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Antithyroid drugs; caesarean section; hyperthyroidism; perinatal outcome; propylthiouracil

Indexed keywords

ANTITHYROID AGENT; CARBIMAZOLE PLUS METHIMAZOLE; PROPYLTHIOURACIL; UNCLASSIFIED DRUG;

ADULT; ADVERSE OUTCOME; ANEMIA; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; HUMAN; HYPEREMESIS GRAVIDARUM; HYPERLIPIDEMIA; HYPERTHYROIDISM; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PERINATAL DRUG EXPOSURE; POPULATION BASED CASE CONTROL STUDY; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SMALL FOR DATE INFANT; TAIWAN;

ADULT; ANTITHYROID AGENTS; CARBIMAZOLE; CASE-CONTROL STUDIES; CONGENITAL ABNORMALITIES; FEMALE; HUMANS; HYPERTHYROIDISM; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; LOGISTIC MODELS; MALE; METHIMAZOLE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREMATURE BIRTH; PREVALENCE; PROPYLTHIOURACIL; TAIWAN; YOUNG ADULT;

EID: 80052749267     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2011.03019.x     Document Type: Article

References (46)

1. Demers LM,. Thyroid disease: pathophysiology and diagnosis. Clin Lab Med 2004; 24: 19-28. (Pubitemid 38638107)
2. Zen XX, Yuan Y, Liu Y, Wu TX, Han S,. Chinese herbal medicines for hyperthyroidism. Cochrane Database Syst Rev (Online) 2007; 18: CD005450.
3. Neale D, Burrow G,. Thyroid disease in pregnancy. Obstet Gynecol Clin North Am 2004; 31: 893-905, xi. (Pubitemid 39531573)
4. Cooper DS,. Hyperthyroidism. Lancet 2003; 362: 459-68. (Pubitemid 36999712)
5. Farling PA,. Thyroid disease. Br J Anaesth 2000; 85: 15-28. (Pubitemid 30417219)
6. Laurberg P, Bournaud C, Karmisholt J, Orgiazzi J,. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. Eur J Endocrinol 2009; 160: 1-8.
7. Lazarus JH, Premawardhana LD,. Screening for thyroid disease in pregnancy. J Clin Pathol 2005; 58: 449-52. (Pubitemid 40646862)
8. Lazarus JH,. Epidemiology and prevention of thyroid disease in pregnancy. Thyroid 2002; 12: 861-5. (Pubitemid 35332990)
9. Mandel SJ, Cooper DS,. The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab 2001; 86: 2354-9. (Pubitemid 32545676)
10. Mestman JH,. Hyperthyroidism in pregnancy. Best Pract Res 2004; 18: 267-88.
11. Phoojaroenchanachai M, Sriussadaporn S, Peerapatdit T, Vannasaeng S, Nitiyanant W, Boonnamsiri V, et al., Effect of maternal hyperthyroidism during late pregnancy on the risk of neonatal low birth weight. Clin Endocrinol 2001; 54: 365-70. (Pubitemid 32234201)
12. Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH,. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 1994; 84: 946-9. (Pubitemid 24360253)
13. Lazarus JH, Kokandi A,. Thyroid disease in relation to pregnancy: a decade of change. Clin Endocrinol 2000; 53: 265-78.
14. Luewan S, Chakkabut P, Tongsong T,. Outcomes of pregnancy complicated with hyperthyroidism: a cohort study. Arch Gynecol Obstet 2011; 283: 243-7.
15. Mitsuda N, Tamaki H, Amino N, Hosono T, Miyai K, Tanizawa O,. Risk factors for developmental disorders in infants born to women with Graves disease. Obstet Gynecol 1992; 80: 359-64.
16. Galofre JC, Davies TF,. Autoimmune thyroid disease in pregnancy: a review. J Womens Health (2002) 2009; 18: 1847-56.
17. Momotani N, Ito K, Hamada N, Ban Y, Nishikawa Y, Mimura T,. Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol 1984; 20: 695-700. (Pubitemid 14105342)
18. Mestman JH,. Hyperthyroidism in pregnancy. Endocrinol Metab Clin North Am 1998; 27: 127-49. (Pubitemid 28144959)
19. Barwell J, Fox GF, Round J, Berg J,. Choanal atresia: the result of maternal thyrotoxicosis or fetal carbimazole? Am J Med Genet 2002; 111: 55-6. (Pubitemid 34761581)
20. Clark SM, Saade GR, Snodgrass WR, Hankins GD,. Pharmacokinetics and pharmacotherapy of thionamides in pregnancy. Ther Drug Monit 2006; 28: 477-83. (Pubitemid 44181481)
21. Cooper DS,. Antithyroid drugs. N Engl J Med 2005; 352: 905-17. (Pubitemid 40300299)
22. Clementi M, Di Gianantonio E, Pelo E, Mammi I, Basile RT, Tenconi R,. Methimazole embryopathy: delineation of the phenotype. Am J Med Genet 1999; 83: 43-6. (Pubitemid 29104474)
23. Kannan L, Mishra S, Agarwal R, Kartikeyan V, Gupta N, Kabra M,. Carbimazole embryopathy-bilateral choanal atresia and patent vitello-intestinal duct: a case report and review of literature. Birth Defects Res 2008; 82: 649-51.
24. Myers AK, Reardon W,. Choanal atresia-a recurrent feature of foetal carbimazole syndrome. Clin Otolaryngol 2005; 30: 375-7. (Pubitemid 41075983)
25. Wilson LC, Kerr BA, Wilkinson R, Fossard C, Donnai D,. Choanal atresia and hypothelia following methimazole exposure in utero: a second report. Am J Med Genet 1998; 75: 220-2. (Pubitemid 28034506)
26. Wolf D, Foulds N, Daya H,. Antenatal carbimazole and choanal atresia: a new embryopathy. Arch Otolaryngol Head Neck Surg 2006; 132: 1009-11. (Pubitemid 44423385)
27. Wing DA, Millar LK, Koonings PP, Montoro MN, Mestman JH,. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol 1994; 170: 90-5. (Pubitemid 24084037)
28. Di Gianantonio E, Schaefer C, Mastroiacovo PP, Cournot MP, Benedicenti F, Reuvers M, et al., Adverse effects of prenatal methimazole exposure. Teratology 2001; 64: 262-6. (Pubitemid 33032708)
29. Wang LH, Lin HC, Lin CC, Chen YH, Lin HC,. Increased risk of adverse pregnancy outcomes in women receiving zolpidem during pregnancy. Clin Pharmacol Ther 2010; 88: 369-74.
30. Lin HL, Chen YH, Lin HC, Lin HC,. No increase in adverse pregnancy outcomes for women receiving antiepileptic drugs. J Neurol 2009; 256: 1742-9.
31. Hennessy S, Bilker WB, Berlin JA, Strom BL,. Factors influencing the optimal control-to-case ratio in matched case-control studies. Am J Epidemiol 1999; 149: 195-7. (Pubitemid 29039523)
32. Newburn-Cook CV, Onyskiw JE,. Is older maternal age a risk factor for preterm birth and fetal growth restriction? A systematic review. Health Care Women Int 2005; 26: 852-75. (Pubitemid 41587370)
33. Hsieh WS, Wu HC, Jeng SF, Liao HF, Su YN, Lin SJ, et al., Nationwide singleton birth weight percentiles by gestational age in Taiwan, 1998-2002. Acta Paediatr Taiwan 2006; 47: 25-33.
34. Savitz DA, Ananth CV, Berkowitz GS, Lapinski R,. Concordance among measures of pregnancy outcome based on fetal size and duration of gestation. Am J Epidemiol 2000; 151: 627-33. (Pubitemid 30463609)
35. Rosenfeld H, Ornoy A, Shechtman S, Diav-Citrin O,. Pregnancy outcome, thyroid dysfunction and fetal goitre after in utero exposure to propylthiouracil: a controlled cohort study. Br J Clin Pharmacol 2009; 68: 609-17.
36. Smith C, Thomsett M, Choong C, Rodda C, McIntyre HD, Cotterill AM,. Congenital thyrotoxicosis in premature infants. Clin Endocrinol 2001; 54: 371-6. (Pubitemid 32234202)
37. Yamashita Y, Yamane K, Fujikawa R, Okubo M, Kohno N,. A successful pregnancy and delivery case of Graves' disease with myeloperoxidase antineutrophil cytoplasmic antibody induced by propylthiouracil. Endocr J 2002; 49: 555-9. (Pubitemid 35334002)
38. Diav-Citrin O, Ornoy A,. Teratogen update: antithyroid drugs-methimazole, carbimazole, and propylthiouracil. Teratology 2002; 65: 38-44. (Pubitemid 34024457)
39. Karras S, Tzotzas T, Kaltsas T, Krassas GE,. Pharmacological treatment of hyperthyroidism during lactation: review of the literature and novel data. Pediatr Endocrinol Rev 2010; 8: 25-33.
40. Mortimer RH, Cannell GR, Addison RS, Johnson LP, Roberts MS, Bernus I,. Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab 1997; 82: 3099-102. (Pubitemid 27385681)
41. Gardner DF, Cruikshank DP, Hays PM, Cooper DS,. Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: correlation of maternal PTU concentrations with cord serum thyroid function tests. J Clin Endocrinol Metab 1986; 62: 217-20. (Pubitemid 16186869)
42. Momotani N, Noh JY, Ishikawa N, Ito K,. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. J Clin Endocrinol Metab 1997; 82: 3633-6. (Pubitemid 27509348)
43. Kriplani A, Buckshee K, Bhargava VL, Takkar D, Ammini AC,. Maternal and perinatal outcome in thyrotoxicosis complicating pregnancy. Eur J Obstet Gynecol Reprod Biol 1994; 54: 159-63.
44. Wang W, Teng W, Shan Z, Wang S, Li J, Zhu L, et al., The prevalence of thyroid disorders during early pregnancy in China: the benefits of universal screening in the first trimester of pregnancy. Eur J Endocrinol 2011; 164: 263-8.
45. Nordeng H, Koren G, Einarson A,. Pregnant women's beliefs about medications-a study among 866 Norwegian women. Ann Pharmacother 2010; 44: 1478-84.
46. Clementi M, Di Gianantonio E, Cassina M, Leoncini E, Botto LD, Mastroiacovo P,. Treatment of hyperthyroidism in pregnancy and birth defects. J Clin Endocrinol Metab 2010; 95: E337-41.